QUIDELORTHO CORP (QDEL)

US2197981051 - Common Stock

39.12  +0.86 (+2.25%)

After market: 39.12 0 (0%)

Fundamental Rating

5

Overall QDEL gets a fundamental rating of 5 out of 10. We evaluated QDEL against 196 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of QDEL while its profitability can be described as average. QDEL is valued quite cheap, while showing a decent growth score. This is a good combination!



6

1. Profitability

1.1 Basic Checks

In the past year QDEL was profitable.
In the past year QDEL had a positive cash flow from operations.
QDEL had positive earnings in 4 of the past 5 years.
QDEL had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a decent Return On Assets value of -0.12%, QDEL is doing good in the industry, outperforming 71.43% of the companies in the same industry.
QDEL has a Return On Equity of -0.20%. This is in the better half of the industry: QDEL outperforms 71.94% of its industry peers.
The Return On Invested Capital of QDEL (2.49%) is better than 72.96% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for QDEL is significantly above the industry average of 8.50%.
The 3 year average ROIC (14.73%) for QDEL is well above the current ROIC(2.49%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.12%
ROE -0.2%
ROIC 2.49%
ROA(3y)11.68%
ROA(5y)17.27%
ROE(3y)15.81%
ROE(5y)24.25%
ROIC(3y)14.73%
ROIC(5y)21.17%

1.3 Margins

QDEL has a Operating Margin of 8.42%. This is in the better half of the industry: QDEL outperforms 76.02% of its industry peers.
QDEL's Operating Margin has declined in the last couple of years.
QDEL has a Gross Margin (49.85%) which is comparable to the rest of the industry.
QDEL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.42%
PM (TTM) N/A
GM 49.85%
OM growth 3Y-49.14%
OM growth 5Y-16.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15%
GM growth 5Y-3.78%

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), QDEL is creating some value.
Compared to 1 year ago, QDEL has more shares outstanding
Compared to 5 years ago, QDEL has more shares outstanding
QDEL has a better debt/assets ratio than last year.

2.2 Solvency

QDEL has a debt to FCF ratio of 8.62. This is a slightly negative value and a sign of low solvency as QDEL would need 8.62 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.62, QDEL is in the better half of the industry, outperforming 77.55% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that QDEL is not too dependend on debt financing.
The Debt to Equity ratio of QDEL (0.45) is worse than 61.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 8.62
Altman-Z N/A
ROIC/WACC0.25
WACC9.79%

2.3 Liquidity

QDEL has a Current Ratio of 1.30. This is a normal value and indicates that QDEL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of QDEL (1.30) is worse than 86.73% of its industry peers.
A Quick Ratio of 0.73 indicates that QDEL may have some problems paying its short term obligations.
The Quick ratio of QDEL (0.73) is worse than 91.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.73

4

3. Growth

3.1 Past

The earnings per share for QDEL have decreased strongly by -76.55% in the last year.
QDEL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.32% yearly.
QDEL shows a decrease in Revenue. In the last year, the revenue decreased by -8.21%.
The Revenue has been growing by 41.83% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-76.55%
EPS 3Y-40.82%
EPS 5Y6.32%
EPS growth Q2Q-33.52%
Revenue 1Y (TTM)-8.21%
Revenue growth 3Y21.74%
Revenue growth 5Y41.83%
Revenue growth Q2Q-14.3%

3.2 Future

Based on estimates for the next years, QDEL will show a small growth in Earnings Per Share. The EPS will grow by 2.98% on average per year.
The Revenue is expected to grow by 3.27% on average over the next years.
EPS Next Y51.43%
EPS Next 2Y-1.64%
EPS Next 3Y2.98%
EPS Next 5YN/A
Revenue Next Year5.62%
Revenue Next 2Y2.21%
Revenue Next 3Y3.27%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.47, which indicates a very decent valuation of QDEL.
Based on the Price/Earnings ratio, QDEL is valued cheaply inside the industry as 97.45% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 24.76, QDEL is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.26, the valuation of QDEL can be described as very cheap.
Based on the Price/Forward Earnings ratio, QDEL is valued cheaper than 99.49% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.26, QDEL is valued rather cheaply.
Industry RankSector Rank
PE 9.47
Fwd PE 6.26

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, QDEL is valued cheaper than 97.45% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.33
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
QDEL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.18
PEG (5Y)1.5
EPS Next 2Y-1.64%
EPS Next 3Y2.98%

0

5. Dividend

5.1 Amount

No dividends for QDEL!.
Industry RankSector Rank
Dividend Yield N/A

QUIDELORTHO CORP

NASDAQ:QDEL (4/19/2024, 7:12:15 PM)

After market: 39.12 0 (0%)

39.12

+0.86 (+2.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.62B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 9.47
Fwd PE 6.26
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.18
PEG (5Y)1.5
Profitability
Industry RankSector Rank
ROA -0.12%
ROE -0.2%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.42%
PM (TTM) N/A
GM 49.85%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.3
Quick Ratio 0.73
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-76.55%
EPS 3Y-40.82%
EPS 5Y
EPS growth Q2Q
EPS Next Y51.43%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-8.21%
Revenue growth 3Y21.74%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y